REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,608 | -15.8% | 73,613 | -18.7% | 0.00% | 0.0% |
| Q2 2023 | $2,421,036 | +59.9% | 90,506 | +29.5% | 0.00% | 0.0% |
| Q1 2023 | $1,514,034 | +11.5% | 69,900 | +22.6% | 0.00% | +100.0% |
| Q4 2022 | $1,357,834 | +23.2% | 57,004 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $1,102,000 | +39.5% | 55,874 | +37.9% | 0.00% | 0.0% |
| Q2 2022 | $790,000 | -31.5% | 40,508 | -10.3% | 0.00% | 0.0% |
| Q1 2022 | $1,153,000 | -1.0% | 45,180 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $1,165,000 | +31.8% | 46,304 | +44.0% | 0.00% | – |
| Q3 2021 | $884,000 | +1.7% | 32,153 | +17.4% | 0.00% | – |
| Q2 2021 | $869,000 | +20.2% | 27,382 | +74.0% | 0.00% | – |
| Q1 2021 | $723,000 | -65.1% | 15,741 | -69.9% | 0.00% | -100.0% |
| Q4 2020 | $2,070,000 | +163.0% | 52,286 | +131.5% | 0.00% | – |
| Q3 2020 | $787,000 | +232.1% | 22,588 | +200.3% | 0.00% | – |
| Q2 2020 | $237,000 | – | 7,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |